Ralliant (NYSE:RAL) Hits New 52-Week High – Here’s What Happened

Ralliant Corporation (NYSE:RAL) hit a new 52-week high during trading on Monday . The company traded as high as $67.01 and last traded at $67.58, with a volume of 1176914 shares traded. The stock had previously closed at $66.08.

Wall Street Analyst Weigh In

RAL has been the topic of a number of recent analyst reports. Wall Street Zen cut Ralliant from a “buy” rating to a “hold” rating in a research report on Sunday, May 31st. TD Cowen raised their price objective on Ralliant from $55.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, May 20th. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. Truist Financial restated a “buy” rating and issued a $68.00 price target (up from $53.00) on shares of Ralliant in a research note on Wednesday, May 13th. Finally, Vertical Research downgraded shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 27th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $67.30.

Ralliant Stock Performance

The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.73. The stock has a market cap of $7.59 billion and a price-to-earnings ratio of -6.20. The company’s 50-day simple moving average is $53.04 and its 200-day simple moving average is $49.85.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.08. The firm had revenue of $534.60 million for the quarter. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Analysts predict that Ralliant Corporation will post 2.64 EPS for the current fiscal year.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th will be given a $0.05 dividend. The ex-dividend date is Monday, June 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s payout ratio is -1.83%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in RAL. Danske Bank A S purchased a new position in Ralliant during the 4th quarter worth approximately $25,000. V Square Quantitative Management LLC acquired a new stake in shares of Ralliant during the 4th quarter valued at $26,000. Allworth Financial LP boosted its stake in shares of Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after buying an additional 293 shares during the period. Palisade Asset Management LLC bought a new stake in Ralliant in the third quarter worth $26,000. Finally, BOKF NA bought a new stake in Ralliant in the third quarter worth $29,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.